CALT Annual Total Long Term Liabilities
$110.99 M
+$28.33 M+34.28%
31 December 2023
Summary:
As of February 5, 2025, CALT annual total long term liabilities is $110.99 million, with the most recent change of +$28.33 million (+34.28%) on December 31, 2023. During the last 3 years, it has risen by +$98.53 million (+791.11%).CALT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALT Quarterly Long Term Liabilities
$114.07 M
+$5.18 M+4.76%
30 June 2024
Summary:
As of February 5, 2025, CALT quarterly total long term liabilities is $114.07 million, with the most recent change of +$5.18 million (+4.76%) on June 30, 2024. Over the past year, it has increased by +$5.18 million (+4.76%).CALT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALT Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +34.3% | +4.8% |
3 y3 years | +791.1% | +244.1% |
5 y5 years | +100.0% | +10000.0% |
CALT Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | at high | at high |
Calliditas Therapeutics AB (Publ) Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $114.07 M(+4.8%) |
Mar 2024 | - | $108.89 M(-1.9%) |
Dec 2023 | $110.99 M(+34.3%) | $110.99 M(+32.4%) |
Sept 2023 | - | $83.80 M(-0.5%) |
June 2023 | - | $84.21 M(+1.9%) |
Dec 2022 | $82.65 M(+136.5%) | $82.65 M(+60.9%) |
Sept 2022 | - | $51.36 M(-6.1%) |
June 2022 | - | $54.68 M(+65.0%) |
Mar 2022 | - | $33.15 M(-5.2%) |
Dec 2021 | $34.95 M(+180.6%) | $34.95 M(-9.1%) |
Sept 2021 | - | $38.45 M(+135.9%) |
June 2021 | - | $16.29 M(+3.4%) |
Mar 2021 | - | $15.75 M(+26.5%) |
Dec 2020 | $12.45 M | $12.45 M(+3666.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $330.70 K(+35.6%) |
June 2020 | - | $243.90 K(-5.5%) |
Mar 2020 | - | $258.10 K(-35.8%) |
Dec 2019 | $402.30 K(>+9900.0%) | $402.30 K(-7.5%) |
Sept 2019 | - | $435.00 K(-17.3%) |
June 2019 | - | $526.10 K(>+9900.0%) |
Mar 2019 | - | $0.00(0.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00 |
Dec 2016 | $0.00(0.0%) | - |
Dec 2015 | $0.00 | - |
FAQ
- What is Calliditas Therapeutics AB (publ) annual total long term liabilities?
- What is the all time high annual total long term liabilities for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) annual total long term liabilities year-on-year change?
- What is Calliditas Therapeutics AB (publ) quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) quarterly long term liabilities year-on-year change?
What is Calliditas Therapeutics AB (publ) annual total long term liabilities?
The current annual total long term liabilities of CALT is $110.99 M
What is the all time high annual total long term liabilities for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high annual total long term liabilities is $110.99 M
What is Calliditas Therapeutics AB (publ) annual total long term liabilities year-on-year change?
Over the past year, CALT annual total long term liabilities has changed by +$28.33 M (+34.28%)
What is Calliditas Therapeutics AB (publ) quarterly total long term liabilities?
The current quarterly long term liabilities of CALT is $114.07 M
What is the all time high quarterly long term liabilities for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high quarterly total long term liabilities is $114.07 M
What is Calliditas Therapeutics AB (publ) quarterly long term liabilities year-on-year change?
Over the past year, CALT quarterly total long term liabilities has changed by +$5.18 M (+4.76%)